Myriad Genetics, Inc.MYGNNASDAQ
Loading
Year-over-year debt growth rate
Percentile
P49
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -1.18% |
| Q3 2025 | 37.32% |
| Q2 2025 | -1.90% |
| Q1 2025 | 12.33% |
| Q4 2024 | -1.96% |
| Q3 2024 | -0.14% |
| Q2 2024 | -2.38% |
| Q1 2024 | -3.48% |
| Q4 2023 | -24.48% |
| Q3 2023 | -1.18% |
| Q2 2023 | 26.11% |
| Q1 2023 | 11.45% |
| Q4 2022 | 5.61% |
| Q3 2022 | 36.35% |
| Q2 2022 | 12.01% |
| Q1 2022 | -2.60% |
| Q4 2021 | -1.28% |
| Q3 2021 | -53.41% |
| Q2 2021 | -7.68% |
| Q1 2021 | -24.78% |
| Q4 2020 | -0.93% |
| Q3 2020 | -1.05% |
| Q2 2020 | 0.27% |
| Q1 2020 | -0.88% |
| Q4 2019 | -1.33% |
| Q3 2019 | 28.74% |
| Q2 2019 | -11.35% |
| Q1 2019 | -3.62% |
| Q4 2018 | 5.93% |
| Q3 2018 | 2674.19% |
| Q2 2018 | -86.58% |
| Q1 2018 | 60.42% |
| Q4 2017 | -41.62% |
| Q3 2017 | -25.33% |
| Q2 2017 | -40.69% |
| Q1 2017 | -18.09% |
| Q4 2016 | 2.41% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |